Related Experiment Video
Updated: Oct 2, 2026
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
Flumazenil responsive ornithine transcarbamylase deficiency encephalopathy: clinical and radiographic features
Michael A Meyer1, Ralitza H Gavrilova
1Positron Emission Tomography Imaging Division, Lucy Dent Imaging Center, Dent Neurologic Institute, Buffalo, New York, USA. mmeyer@dentinstitute.com
Abstract:
A 22-year-old woman with a negative urine drug screen and somnolence rapidly reversed by intravenous flumazenil was found to have elevated ammonia levels and punctate calcifications of the subcortical frontal white matter. Abnormally high levels of orotic acid were found in serum and urine, confirming the diagnosis of ornithine transcarbamylase deficiency. Although computed tomography findings are non-specific, young patients with unexplained hyperammonemic states of somnolence reversed by flumazenil should be screened for this X-linked recessive metabolic disorder.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis l: Introduction
Rocky Mountain Spotted Fever
Encephalitis ll: Pathophysiology
REM Sleep Behavior Disorder
RBD is significantly associated with...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
